AI + EXCLUSIVE DATA
AI analyzes funding data you can't access anywhere else
Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.
10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + real-time funding intelligence
✓Never see duplicates in your feed
INDUSTRY FIRST
Gaingels Aspen Neuroscience Llc announced it raised $375,000 in an initial filing from an offering of $375,000
May 10, 2022•over 3 years ago
Amount Raised
$375,000
Round Type
seed
San DiegoBiotechnologyCompany Information
Location
10835 Road to the Cure, Ste. 100
San Diego, California, United States
About
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.
Company News
(10 articles)Mon, 09 Jun 2025 07:00:00 GMT
Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting - PR Newswire
Mon, 13 Jan 2025 08:00:00 GMT
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson's Disease - PR Newswire
Wed, 08 Jan 2025 08:00:00 GMT
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease - Business Wire
Wed, 14 May 2025 07:00:00 GMT
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting - PR Newswire
Wed, 30 Apr 2025 07:00:00 GMT
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer - PR Newswire
Tue, 16 Jan 2024 08:00:00 GMT
Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer - PR Newswire
Thu, 30 May 2024 07:00:00 GMT
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting - PR Newswire
Thu, 24 Aug 2023 07:00:00 GMT
Rune Labs and Aspen Neuroscience Collaborate to Deeply Characterize Symptom Activity in Parkinson's Disease (PD) for Upcoming Trial-Ready Cohort Screening Study - PR Newswire
Tue, 21 Nov 2023 08:00:00 GMT
Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award - PR Newswire
Wed, 14 Feb 2024 08:00:00 GMT
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead - PR Newswire
FundzWatch™ Score
85
Medium Activity
Related People
Sign in to view contact details
Sign in to view contact details
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech